Personalizing the duration of androgen-deprivation therapy use in the management of intermediate-risk prostate cancer
- PMID: 25534385
- DOI: 10.1200/JCO.2014.59.0968
Personalizing the duration of androgen-deprivation therapy use in the management of intermediate-risk prostate cancer
Comment on
-
Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.J Clin Oncol. 2015 Feb 1;33(4):332-9. doi: 10.1200/JCO.2014.58.0662. Epub 2014 Dec 22. J Clin Oncol. 2015. PMID: 25534388 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
